Interpretation of chronic pain clinical trial outcomes: IMMPACT recommended considerations

od Smith, Shannon M., Dworkin, Robert H., Turk, Dennis C., McDermott, Michael, Eccleston, Christopher, Farrar, John T., Rowbotham, Michael C., Bhangwagar, Zubin, Burke, Laurie B., Cowan, Penney, Ellenberg, Susan S., Evans, Scott R., Freeman, Roy L., Garrison, Louis P., Iyengar, Smriti, Jadad, Alejandro, Jensen, Mark P., Junor, Roderick, Kamp, Cornelia, Katz, Nathaniel P., Kesslak, J. Patrick, Kopecky, Ernest A., Lissin, Dmitri, Markman, John D., Mease, Philip J., O’Connor, Alec B., Patel, Kushang V., Raja, Srinivasa N., Sampaio, Cristina, Schoenfeld, David, Singh, Jasvinder, Steigerwald, Ilona, Strand, Vibeke, Tive, Leslie A., Tobias, Jeffrey, Wasan, Ajay D., Wilson, Hilary D.
Izdano u Pain (2020)

Core outcome measures for opioid abuse liability laboratory assessment studies in humans: IMMPACT recommendations

od Comer, Sandra D., Zacny, James P., Dworkin, Robert H., Turk, Dennis C., Bigelow, George E., Foltin, Richard W., Jasinski, Donald R., Sellers, Edward M., Adams, Edgar H., Balster, Robert, Burke, Laurie B., Cerny, Igor, Colucci, Robert D., Cone, Edward, Cowan, Penney, Farrar, John T., Haddox, J. David, Haythornthwaite, Jennifer A., Hertz, Sharon, Jay, Gary W., Johanson, Chris-Ellyn, Junor, Roderick, Katz, Nathaniel P., Klein, Michael, Kopecky, Ernest A., Leiderman, Deborah B., McDermott, Michael P., O’Brien, Charles, O’Connor, Alec B., Palmer, Pamela P., Raja, Srinivasa N., Rappaport, Bob A., Rauschkolb, Christine, Rowbotham, Michael C., Sampaio, Cristina, Setnik, Beatrice, Sokolowska, Marta, Stauffer, Joseph W., Walsh, Sharon L.
Izdano 2012